The impact of ART (anti-retrovial treatment) scale-up on health systems de-strengthening in sub-Saharan Africa: Justice and justification

Medicine and Law

Volumn 27, Issue 3, 2008, Pages 685-703

  Nixon, Stephanie ^a,b   Veenstra, Nina ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

ART scale up; Health system strengthening; HIV AIDS; Sub Saharan Africa

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MICROBICIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; DRUG COST; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MATERNAL CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PUBLIC HEALTH SERVICE; SEXUAL TRANSMISSION; SOCIAL DISCRIMINATION; SOCIAL JUSTICE; VERTICAL TRANSMISSION;

EID: 54549096830     PISSN: 07231393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. R. Loewenson and D. McCoy, Access to antiretroviral treatment in Africa, British Medical Journal 328, 241-242 (2004).
2. UNAIDS, Report of the global AIDS epidemic 2006, UNAIDS, Geneva (2006).
3. Declaration of Alma-Ata, International Conference on Primary Health Care, Alma-Ata, USSR (1978).
4. M. Cueto, The origins of primary health care and selective primary health care, American Journal of Public Health 94 (11), 1864-1874 (2004).
5. World Bank, World Development Report 1993: Investing in health, World Bank, Washington (1993).
6. See, for example J. Nabyonga, M. Desmet, H. Karamagi, P. Kadama, F. Omaswa and O. Walker, Abolition of cost-sharing is pro-poor: evidence from Uganda, Health Policy and Planning 20 (2), 100-108 (2005).
7. Global Health Watch, Global Health Watch 2005-2006: An alternative world health report, People's Health Movement, Medact and Global Equity Gauge Alliance (2005).
8. People's Health Movement, People's Charter for Health, First People's Health Assembly, Dhaka, Bangladesh (2000).
9. D. Blaauw, L. Gilson, P. Modiba, E. Erasmus, G. Khumalo and H. Scheider, Governmental relationships and HIV/AIDS service delivery, Centre for Health Policy (CHP), University of Witwatersrand, Johannesburg (2004).
10. A. Mills, Mass campaigns versus general health services: what have we learnt in 40 years about vertical versus horizontal approaches?, Bulletin of the World Health Organization 83 (4), 315-316 (2005).
11. V. Oliveira-Cruz, C. Kurowski and A. Mills, Delivery of priority health services: searching for synergies within the vertical versus horizontal debate, Journal of International Development 15, 67-86 (2003).
12. A. Mills, Vertical vs horizontal health programmes in Africa: idealism, pragmatism, resources and efficiency, Social Science and Medicine 17 (24), 1971-1981 (1983).
13. WHO, The African Regional Health Report: The health of the people, World Health Organisation, Geneva (2006).
14. K. Kober and W. Van Damme, Scaling up access to antiretroviral treatment in southern Africa: who will do the job?, The Lancet 364 (9428), 103-107 (2004).
15. Global Health Watch, Global Health Watch 2005-2006: An alternative world health report, People's Health Movement, Medact and Global Equity Gauge Alliance (2005).
16. M. Over, 'Impact of the HIV/AIDS epidemic on the health sectors of developing countries', In M. Haacker (ed.), The Macroeconomics of HIV/ AIDS, International Monetary Fund, Washington (2004).
17. E. Beck, S. Mandalia, I. Williams, A. Power, R. e. a. Newson and for the NPMS Steering Group, Decreased morbidity and use of hospital services in English HIV infected individuals with increased uptake of anti-retroviral therapy 1996-1997, AIDS 13, 2157-2164 (1999).
18. M. Stoll, C. Class, E. Scuttle, J. Von Der Scullenburg and R. Schmidt, Direct costs for the treatment of HIV-infection in a German cohort after introduction of HAART, European Journal of Medical Research 7, 463-471 (2002).
19. I. Dourado, M. Amélia, D. Barriera and A. Maria, AIDS epidemic trends after the introduction of antiretroviral therapy in Brazil, Rev Saúde Pública 40 (Suppl), 9-17 (2006).
20. A. Creese, K. Floyd, A. Alban and L. Guiness, Cost-effectiveness of BIV/ AIDS interventions in Africa: a systematic review of the evidence, The Lancet 359, 1635-1642 (2002).
21. E. Marseille, P. Hofmann and J. Kahn, HIV prevention before HAART in sub-Saharan Africa, The Lancet 359, 1851-1856 (2002).
22. D. Coetzee, K. Hildebrand, A. Boulle, G. Maartens, F. Louis, V. Labatala, H. Reuter, N. Ntwana and E. Goemaere, Outcomes after two years of providing antiretroviral treatment in Khayelitsha, AIDS 18 (6), 887-895 (2004).
23. P. Fanner, F. Leandre, J. Mukherjee, M. Claude, P. Nevil, M. Smith-Fawzi, S. Koenig, A. Castro, M. Becerra, J. Sachs, A. Attaran and J. Kim, Community-based approaches to HIV treatment in resource-poor settings, The Lancet 358, 404409 (2001).
24. C. Akileswaran, M. Jurie, T. Flanigan and K. Mayer, Lessons learned from use of highly active antiretroviral therapy in Africa, Clinical Infectious Diseases 41, 376-385 (2005).
25. L. Ferradini, A. Jeannin, L. Pinoges, J. Izopet, D. Odhiambo, L. Mankhambo, G. Karungi, E. Szumilin, S. Balandine and G. Fedida, Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment, The Lancet 367, 13335-13339 (2006).
26. see for example S. Lawn, L. Myer, C. Orrell, L. Bekker and R. Wood, Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design, AIDS 19, 2141-2148 (2005).
27. P. Weidle, S. Malamba, R. Mwebaze, C. Sozi, G. Rukundo, R. Downing, D. Hanson, D. Ochola, P. Mugyenyi, J. Mermin, B. Samb and E. Lackritz, Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance, The Lancet 360, 34-40 (2002).
28. M. Bachmann, Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults, AIDS Care 18 (2), 109-120 (2006).
29. E. Mills, J. Nachega, I. Buchan, J. Orbinski, A. Attaran, S. Singh, B. Rachlis, P. Wu, C. Cooper, L. Thabane, K. Wilson, G. Guyatt and D. Bangsberg, Adherence to antiretroviral therapy in sub-Saharan Africa and North America, Journal of the American Medical Association 296 (6), 679-690 (2006).
30. A. Harries, D. Nyangulu, N. Hargreaves, O. Kaluwa and F. Salaniponi, Preventing antiretroviral anarchy in sub-Saharan Africa, The Lancet 358, 410-414 (2001).
31. W. Stevens, S. Kaye and T. Gorrah, Antiretroviral therapy in Africa, British Medical Journal 328, 280-282 (2004).
32. G. Mshana, J. Wamoyi, J. Busza, B. Zaba, J. Changalucha, S. Kaluvya and M. Urassa, Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program, AIDS Patient Care and STI)s 20 (9), 649-657 (2006).
33. A. Padarath, C. Searle, Z. Sibiya, E. Williams and M. Ntsike, Understanding barriers and challenges to community participation in HIV and ARV services, 3rd Public Health Conference 2006 'Making health systems work', Midrand, South Africa (2006).
34. S. Weiser, W. Wolfe, D. Bangsberg, I. Thior, P. Gilbert, J. Makhema, P. Kebaabetswe, D. Dickenson, K. Mompati, M. Essex and R. Marlink, Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana, Journal of Acquired Immune Deficiency Syndromes 34 (3), 281-288 (2003).
35. G. George, Workplace ART programmes: why do companies invest in them and are they working?, African Journal of AIDS Research 5 (2), 179-188 (2006).
36. S. Leclerc-Madlala, Juggling AIDS, grants and treatment in South Aftica: predicaments of second phase HIV/AIDS, Anthropology Southern Africa Conference: 'Continuity, Change and Transformation: Anthropology in the 21st Century', University of KwaZulu-Natal, Durban (2005).
37. N. Nattrass, Trading-off income and health: AIDS and the disability grant in South Africa, Centre for Social Science Research (CSSR), Cape Town (2004).
38. M. Egger, A. Boulle, M. Schechter and P. Miotti, Antiretroviral therapy in resource-poor settings: scaling up inequalities?, International Journal of Epidemiology 34 (3), 509-512 (2005)
39. See for example J. Castilla, J. Del Romero, V. Hernando, B. Marincovich, S. Garcia and C. Rodriguez, Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HlV, Journal of Acquired Immune Deficiency Syndromes 40 (1), 96-101 (2005).
40. E. Cooper, M. Charurat, L. Mofenson, I. Hanson, J. Pitt, C. Diaz, K. Hayani, I. Handelsman, V. Smeriglio, R. Hoff and W. Blattner, Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission, Journal of Acquired Immune Deficiency Syndromes 29 (5), 484-494 (2002).
41. T. Quinn, M. Wawer, N. Sewankambo, D. Serwadda, C. Li, F. Wabwire-Mangen, M. Meehan, T. Lutato and R. Gray, Viral load and heterosexual transmission of human immunodeficiency virus type 1, New England Journal of Medicine 342 (13), 921-929 (2000).
42. B. Auvert, S. Males, A. Puren, D. Taijaard, M. Caraël and B. Williams, Can highly active antiretroviral therapy reduce the spread of HlV?: A study in a township of South Africa, Journal of Acquired Immune Deficiency Syndromes 36 (1), 613-621 (2004).
43. W. Wolfe, S. Weiser, K. Leiter, W. Steward, F. Percy-de Korte, N. Phaladze, N. Lacopino and A Heisler, Impact of universal access to antiretroviral therapy on HIV stigma in Botswana, XVI International AIDS Conference, Toronto (2006).
44. Y. Dambisya, The fate and career destinations of doctors who qualified at Uganda's Makerere Medical School in 1984: retrospective cohort study, British Medical Journal 329 (7466), 600-601 (2004).
45. M. Mukati, A. Gonani, A. Macheso, B. Simwaka, S. Kinoti and B. Ndyanabangi, Challenges facing the Malawian health workforce in the era of HIV/AIDS, CRHCS/USAID/SARA, (2004).
46. F. Feeley, Fight AIDS as well as the brain drain, The Lancet 368, 435-436 (2006).
47. K. Kiragu, T. Ngulube, M. Nyumbu, P. Njobvu, P. Eerens and C. Mwaba, Sexual risktaking and HIV testing among health workers in Zambia, AIDS and Behaviour 11 (1), 131-136 (2006).
48. J. Zelnick and M. O'Donnell, The impact of the HIV/AIDS epidemic on hospital nurses in KwaZulu-Natal, South Africa: nurses' perspectives and implications for health policy, Journal of Public Health Policy 26 (2), 163-185 (2005).
49. K. Cullinan, Antiretroviral roll-out could be just the tonic - or a bitter pill, Sunday Times, 28 September 2003 (2003).
50. M. Chopra, C. Kendall, Z. Hill, N. Schaay, L. Nkonki and T. Doherty, 'Nothing new': responses to the introduction of antiretroviral drugs in South Africa, AIDS 20,1975-1977 (2006).
51. S. Harmon, Solidarity: a (new) ethic for global health policy, Health Care Analysis 14, 215-236 (2006).
52. R. Atun, F. Lennox-chhugani, F. Drobniewski, Y. Samyshkin and R. Coker, A framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative example, European Journal of Public Health 14, 267-273 (2004).
53. Global Health Watch, Global Health Watch 2005-2006: An alternative world health report, People's Health Movement, Medact and Global Equity Gauge Alliance (2005).
54. P. Travis, S. Bennet, A. Haines, T. Pang, Z. Bhutta, A. Hyder, N. Pielemeier, A. Mills and T. Evans, Overcoming health-systems constraints to achieve the Millenium Development Goals, The Lancet 364, 900-906 (2004).
55. J. Salomon, D. Hogan, J. Stover, K. Stanecki, W. Walker, P. Ghys and B. Schwartländer, Integrating HIV prevention and treatment: from slogans to impact, PLoS Medicine 2 (1), e 16 (2005).
56. R. Loewenson and D. McCoy, Access to antiretroviral treatment in Africa, British Medical Journal 328, 241-242 (2004).
57. A Egger, A. Boulle, M. Schechter and P. Miotti, Antiretroviral therapy in resource-poor settings: scaling up inequalities?, International Journal of Epidemiology 34 (3),509-512 (2005).
58. R. Stewart, A. Padarath and C. Milford, Emerging threats to equitable implementation of ART in South Africa, Acta Academica Supplementum 1, 286-308 (2006).
59. M. Roseman and S. Gruskin, HIV/AIDS & human rights in a nutshell, Harvard School of Public Health and International Council of AIDS Service Organisations (ICASO), Toronto (2004).
60. S. Gimbel-Sherr, A Micek, K. Gimbel-Sherr, T. Koepsell, J. Hughes, K. Thomas, J. Pfeiffer and S. Gloyd, Using nurses to identify HAART eligible patients in the Republic of Mozambique: results of a time series analysis, Human Resources for Health 5, 7 (2007).
61. See, for example, D. Pienaar, L. Myer, S. Cleary, D. Coetzee, D. Michaels, K. Cloete, H. Schneider and A. Boulle, Models of Care for Antiretroviral Service Delivery, School of Public Health and Family Medicine, University of Cape Town, Cape Town (2006).
62. M. Egger, A. Boulle, M. Schechter and P. Miotti, Antiretroviral therapy in resource-poor settings: scaling up inequalities?, Intemational Journal of Epidemiology 34 (3), 509-512 (2005).